{"denoms":[{"counts":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"1"}],"units":"Participants"}],"groups":[{"description":"Patients receive oral methylphenidate extended-release once daily for 7-42 days in the absence of unacceptable toxicity.","id":"BG000","title":"Arm I - Methylphenidate Hydrochloride"},{"description":"Patients receive oral modafinil once daily for 7-42 days in the absence of unacceptable toxicity.","id":"BG001","title":"Arm II -Modafinil"},{"description":"Patients receive oral placebo once daily for 7-42 days in the absence of unacceptable toxicity.","id":"BG002","title":"Arm III Placebo"},{"description":"Total of all reporting groups","id":"BG003","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG003","value":"1"}]}],"title":"<=18 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"Between 18 and 65 years"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":">=65 years"}],"paramType":"NUMBER","title":"Age, Categorical","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"13.9"},{"groupId":"BG003","value":"13.9"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"Female"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG003","value":"1"}]}],"title":"Male"}],"paramType":"NUMBER","title":"Gender","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG003","value":"1"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"}]}